4th Apr 2008 07:01
Tristel PLC04 April 2008 Tristel plc ("Tristel" or "the Company") Director Share Purchase Tristel plc, the AIM listed provider of infection and contamination controlproducts, announces that on the 3rd April 2008 Peter Stephens, Chairman of theRemuneration Committee and Non-Executive Director, purchased 25,000 OrdinaryShares in the Company at 39 pence per share. Following the above purchase Mr Stephens has an interest in 1,085,681 OrdinaryShares in the Company, representing 4.04% the Company's issued share capital. Contacts: Tristel plcPaul Swinney, Chief Executive Tel: 01638 721 500 Daniel Stewart & Company PlcGraham Webster Tel: 020 7776 6576 Parkgreen Communications Ltd Tel: 020 7851 7480Lucy Lake Mob: 07894 263 046 [email protected] Notes to Editors Tristel's core business is the marketing of its proprietary chlorine dioxidechemistry that is highly effective in destroying all types of bacteria(including C difficile, MRSA, bacterial spores, and tuberculosis), fungi andviruses and is one of a small group of sporicidal agents that is safe and easyto use. Tristel plc operates with two divisions, Tristel Solutions and TristelTechnologies. Tristel Solutions focuses on infection control products for NHS and privatesector hospitals, primary care trusts, community hospitals, private practices,dental practices and veterinary establishments. The Company's products are usedon instruments, surfaces, and the skin in over 375 UK hospitals, representingsome 60 per cent of all UK NHS Acute & Private Hospitals. Tristel Technologies provides products for Legionella infection control inbuilding water systems and for contamination control in the food growing andfood processing industries. Tristel Technologies has approximately 200 customersin the government, municipal, industrial, healthcare and food sectors and more40 UK hospitals where its products are used for Legionella control. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Tristel